Parkman Healthcare Partners’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-58,889
Closed -$13.5M 98
2025
Q4
$13.5M Sell
58,889
-51,652
-47% -$11.4M 1.28% 27
2025
Q3
$21.9M Buy
110,541
+451
+0.4% +$89.7K 2.29% 12
2025
Q2
$21.7M Buy
110,090
+46,840
+74% +$9.08M 2.5% 10
2025
Q1
$13M Buy
+63,250
New +$13.8M 1.54% 26
2023
Q3
Sell
-68,465
Closed -$14.6M 105
2023
Q2
$14.6M Buy
68,465
+51,301
+299% +$10.9M 2.53% 11
2023
Q1
$3.84M Sell
17,164
-26,143
-60% -$5.95M 0.83% 42
2022
Q4
$10.2M Sell
43,307
-16,484
-28% -$3.82M 2.71% 9
2022
Q3
$13.7M Buy
59,791
+16,401
+38% +$4.02M 3.89% 3
2022
Q2
$9.75M Buy
43,390
+1,686
+4% +$388K 3.59% 4
2022
Q1
$10.8M Sell
41,704
-24,675
-37% -$6.18M 3.17% 9
2021
Q4
$19.4M Buy
66,379
+15,254
+30% +$4.2M 4.27% 3
2021
Q3
$13.8M Sell
51,125
-11,844
-19% -$3.22M 3.49% 7
2021
Q2
$15M Sell
62,969
-10,334
-14% -$2.29M 3.27% 7
2021
Q1
$14.6M Buy
73,303
+19,512
+36% +$3.96M 3.39% 3
2020
Q4
$10.6M Sell
53,791
-19,538
-27% -$3.92M 2.71% 7
2020
Q3
$14M Buy
73,329
+16,929
+30% +$3.01M 3.71% 2
2020
Q2
$8.84M Buy
+56,400
New +$8.09M 2.49% 8

Other funds holding DHR

Parkman Healthcare Partners's DHR Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Danaher (DHR) in Q1 2026, closing a stake of 58,889 shares — an estimated $13.5M sold.

Parkman Healthcare Partners first reported a position in DHR in Q2 2020 and held it in 17 quarters. The position peaked at $21.9M in Q3 2025. 2,167 funds tracked by Wall St. Rank hold DHR as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Danaher position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 58,889 Danaher shares in Q1 2026, an estimated $13.5M.
  • Parkman Healthcare Partners first reported a position in Danaher in Q2 2020 and held it in 17 quarters.
  • Parkman Healthcare Partners's Danaher position peaked at $21.9M in Q3 2025.
  • 2,167 funds tracked by Wall St. Rank held Danaher as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.